BP001047-PRO-684: Recombinant Human Wnt inhibitory factor 1 (WIF1) protein
Source: Hi-5 Cells-derived.
Purity: > 80.0% by SDS-PAGE.BP000461-VZV-231: Recombinant Varicella Zoster Virus gE
Source: E. coli-derived.
Purity > 95%, by 10% PAGE.
Applications: WBs, ELISA.BP000995-PKA-242: Recombinant Human VEGFR2
Source:Insect Cells-derived.
The activity of VEGFR2 D1-7 was determined by its ability to abolish the binding of iodinated VEGF to solid surfaces or cell surfaces receptors. The ED50 for this effect is typically 10.0 ng/ml, corresponding to a specific activity of 100,000 IU/mg.
Purity > 95%, by SDS-PAGE.BP000995-PKA-243: Recombinant Human VEGFR2 Fc Chimera
Source:Insect Cells-derived.
The activity of sVEGFR-2/Fc was determined by its ability to inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells. The ED50 for this effect is typically 10-30 ng/ml, corresponding to a specific activity of 33,333.33-100,000 units/mg.
Purity > 90%, by SDS-PAGE.BP000027-CYT-260: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, CHO
Source: Chinese Hamster Ovarian Cell-derived.
Determined by its ability to stimulate 3H-Thymidine incorporation in human ublical vein endothelial cells, the ED50 for this effect was found to be 2-6 ng/ml corresponding to a Specific Activity of 166,667-500,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000027-CYT-116: Recombinant Human VEGF (121 a.a) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of HUVEC cells (Human Umbilical Vein Endothelial Cells) and is typically 2-8 ng/ml.
Purity: > 95% by SDS-PAGE.BP000027-CYT-680: Recombinant Mouse Vascular Endothelial Growth Factor (VEGF) Protein, His Tag
Source: E. coli-derived.
Measured in a cell proliferation assay using NIH-3T3 mouse embryonic fibroblast. The ED50 for this effect is 0.5-1.5 ng/ml.
Purity: >90% by SDS-PAGE.BP000027-CYT-343: Recombinant Human Vascular Endothelial Growth Factor (121 a.a) Protein
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 0.2-0.4 ng/ml corresponding to a specific activity of 2.5-5 MU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000027-CYT-496: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, His Tag
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP000027-CYT-619: Recombinant Human VEGF (121 a.a) Protein, His Tag
Source: E. coli-derived.
The ED50 for this effect is <4.2 ng/ml. Measured in a cell proliferation assay using NIH-3T3 cell, corresponding to a specific activity of less than 238,095 units/mg.
Purity: > 95% by SDS-PAGE.